Want to join the conversation?
$PDCO 1Q16 Q&A: Kevin from Piper Jaffray asked about equipment business. Scott said that we're really having lot of potential tailwinds behind us, including the section 179 issue that impacted us last year. I think that will be rectified and then a lot of momentum coming out of CEREC 30. So, we're optimistic about the dental equipment.
Biodefense therapeutics firm $PIP announced an all-stock merger with biotech Altimmune. The respective boards of the two companies unanimously approved the merger.
$YHOO is reporting today after market close. Nobody cares about this stock.